Albemarle (ALB) PT Raised to $162 at Wells Fargo
Get Alerts ALB Hot Sheet
Price: $135.04 +0.57%
Rating Summary:
17 Buy, 17 Hold, 5 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 10 | Down: 13 | New: 20
Rating Summary:
17 Buy, 17 Hold, 5 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 10 | Down: 13 | New: 20
Join SI Premium – FREE
Wells Fargo analyst Edward Kelly raised the price target on Albemarle (NYSE: ALB) to $162.00 (from $125.00) while maintaining a Equal Weight rating.
You May Also Be Interested In
- Unicycive Therapeutics (UNCY) PT Raised to $15 at Benchmark Following Q2 Results
- CrowdStrike (CRWD) PT Raised to $235 at JPMorgan
- HCA Healthcare Inc (HCA) PT Lowered to $425 at JPMorgan
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share